Literature DB >> 16219359

Interactions of vanadium(V)-citrate complexes with the sarcoplasmic reticulum calcium pump.

Manuel Aureliano1, Teresa Tiago, Ricardo M C Gândara, Andrea Sousa, A Moderno, M Kaliva, A Salifoglou, Rui O Duarte, José J G Moura.   

Abstract

Among the biotargets interacting with vanadium is the calcium pump from the sarcoplasmic reticulum (SR). To this end, initial research efforts were launched with two vanadium(V)-citrate complexes, namely (NH(4))(6)[V(2)O(4)(C(6)H(4)O(7))(2)].6H(2)O and (NH(4))(6)[V(2)O(2)(O(2))(2)(C(6)H(4)O(7))(2)].4H(2)O, potentially capable of interacting with the SR calcium pump by combining kinetic studies with (51)V NMR spectroscopy. Upon dissolution in the reaction medium (concentration range: 4-0.5mM), both vanadium(V):citrate (VC) and peroxovanadium(V):citrate (PVC) complexes are partially converted into vanadate oligomers. A 1mM solution of the PVC complex, containing 184microM of the PVC complex, 94microM oxoperoxovanadium(V) (PV) species, 222microM monomeric (V1), 43microM dimeric (V2) and 53microM tetrameric (V4) species, inhibits Ca(2+) accumulation by 75 %, whereas a solution of the VC complex of the same vanadium concentration, containing 98microM of the VC complex, 263microM monomeric (V1), 64microM dimeric (V2) and 92microM tetrameric (V4) species inhibits the calcium pump activity by 33 %. In contrast, a 1 mM metavanadate solution, containing 460microM monomeric (V1), 90.2microM dimeric (V2) and 80microM tetrameric (V4) species, has no effect on Ca(2+) accumulation. The NMR signals from the VC complex (-548.0ppm), PVC complex (-551.5ppm) and PV (-611.1ppm) are broadened upon SR vesicle addition (2.5mg/ml total protein). The relative order for the half width line broadening of the NMR signals, which reflect the interaction with the protein, was found to be V4>PVC>VC>PV>V2=V1=1, with no effect observed for the V1 and V2 signals. Putting it all together the effects of two vanadium(V)-citrate complexes on the modulation of calcium accumulation and ATP hydrolysis by the SR calcium pump reflected the observed variable reactivity into the nature of key species forming upon dissolution of the title complexes in the reaction media.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16219359     DOI: 10.1016/j.jinorgbio.2005.09.002

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  6 in total

1.  Recent perspectives into biochemistry of decavanadate.

Authors:  Manuel Aureliano
Journal:  World J Biol Chem       Date:  2011-10-26

Review 2.  Applications of heteronuclear NMR spectroscopy in biological and medicinal inorganic chemistry.

Authors:  Luca Ronconi; Peter J Sadler
Journal:  Coord Chem Rev       Date:  2008-01-26       Impact factor: 22.315

3.  α-Hydroxy coordination of mononuclear vanadyl citrate, malate and S-citramalate with N-heterocycle ligand, implying a new protonation pathway of iron-vanadium cofactor in nitrogenase.

Authors:  Can-Yu Chen; Mao-Long Chen; Hong-Bin Chen; Hongxin Wang; Stephen P Cramer; Zhao-Hui Zhou
Journal:  J Inorg Biochem       Date:  2014-08-11       Impact factor: 4.155

4.  1,2-Dichlorobenzene affects the formation of the phosphoenzyme stage during the catalytic cycle of the Ca(2+)-ATPase from sarcoplasmic reticulum.

Authors:  Javier Vargas-Medrano; Jorge A Sierra-Fonseca; Luis F Plenge-Tellechea
Journal:  BMC Biochem       Date:  2016-03-11       Impact factor: 4.059

Review 5.  Vanadium in Biological Action: Chemical, Pharmacological Aspects, and Metabolic Implications in Diabetes Mellitus.

Authors:  Samuel Treviño; Alfonso Díaz; Eduardo Sánchez-Lara; Brenda L Sanchez-Gaytan; Jose Manuel Perez-Aguilar; Enrique González-Vergara
Journal:  Biol Trace Elem Res       Date:  2018-10-22       Impact factor: 3.738

Review 6.  ATP Analogues for Structural Investigations: Case Studies of a DnaB Helicase and an ABC Transporter.

Authors:  Denis Lacabanne; Thomas Wiegand; Nino Wili; Maria I Kozlova; Riccardo Cadalbert; Daniel Klose; Armen Y Mulkidjanian; Beat H Meier; Anja Böckmann
Journal:  Molecules       Date:  2020-11-12       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.